Article Summary

This article reports that abortion providers in California are preparing to quickly switch to using misoprostol, a different medication, if the Supreme Court restricts access to mifepristone, the main abortion pill currently used. It highlights that despite legal uncertainty and potential risks with the backup drug, suppliers are ready to continue mailing abortion pills to maintain access. The tone suggests that abortion access will continue one way or another, even if rules change.